Franco Schiavon
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 28, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study.
Journal: Rheumatology (Oxford, England)
Published: December 28, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
Journal: Journal of autoimmunity
Published: October 15, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire.
Journal: Rheumatology advances in practice
Published: February 15, 2024
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients.
Journal: Annals of the rheumatic diseases
Published: January 14, 2023
Biologic therapy in relapsing polychondritis: navigating between options.
Journal: Expert opinion on biological therapy
Published: March 01, 2022
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort.
Journal: Clinical and experimental rheumatology
Published: December 13, 2021
Current clinical and therapeutic approach to tumour-like mass lesions in granulomatosis with polyangiitis.
Journal: Autoimmunity reviews
Published: November 23, 2021
IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
Journal: Journal of autoimmunity
Published: July 20, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 04, 2021
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
Journal: Clinical and experimental rheumatology
Published: February 03, 2021
Health-Related Quality of Life in Patients With ANCA-Associated Vasculitis and Sinonasal Involvement: A Single-Center Cross-Sectional Study.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: November 02, 2020
Last Updated: 09/26/2026